A Phase III, 12 Month, Double Blind, Randomized, Parallel Group, Placebo Controlled, Efficacy and Safety Study of AXOKINE in Overweight and Obese Subjects with a 12-Month Open-Label Extension Phase

  • Anderson, James (PI)
  • FREDERICH JR, ROBERT (CoI)
  • Reynolds, L (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/16/01 → 5/30/04